Shunichi Jinnai

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersArtificial life and complex adaptive systemsDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 14, 2022
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.

Akira Takahashi, Kenjiro Namikawa, Dai Ogata

|Mar 26, 2021
Clinical response to a MEK inhibitor in a patient with metastatic melanoma harboring an RAF1 gene rearrangement detected by cancer gene panel testing.

Kenta Nakama, Dai Ogata, Eiji Nakano

|Dec 02, 2020
Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer.

Keita Tsutsui, Kenjiro Namikawa, Taisuke Mori

|Dec 01, 2020
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine.

Ryuji Hamamoto, Kruthi Suvarna, Masayoshi Yamada

|Aug 06, 2020
The Development of a Skin Cancer Classification System for Pigmented Skin Lesions Using Deep Learning.

Shunichi Jinnai, Naoya Yamazaki, Yuichiro Hirano

|Jul 30, 2020
Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.

Akira Takahashi, Kenjiro Namikawa, Dai Ogata

Pageof 2

Frequent Collaborators

7 joint publications

Kenjiro Namikawa

7 joint publications

Naoya Yamazaki

3 joint publications

Keita Tsutsui

3 joint publications

Yusuke Muto